Galapagos initiates NOVESA Phase 2a trial in patients with systemic sclerosis - Seite 3

---

^[1] Nikpour et al. Curr Opin Rheumatol. 2014

^[2]LeRoy et al. J Rheumatol. 2001; Dobrota et al. Annals Rheum Dis. 2016

^[3]Forced Vital Capacity

^[4] High-resolution computed tomography

^[5] Scleroderma Health Assessment Questionnaire - Disability Index

^[6] Combined Response Index of diffuse cutaneous Systemic Sclerosis

^[7] Idiopathic Pulmonary Fibrosis

PDF file

---

This announcement is distributed by West Corporation on behalf of West Corporation clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Galapagos NV via Globenewswire